Legal Representation
Attorney
Kwang Yup Chae
Application History
35 eventsDate | Code | Type | Description |
---|---|---|---|
Jul 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jan 10, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jan 10, 2025 | EXT4 | S | SOU EXTENSION 4 FILED |
Jan 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jun 25, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
Jun 25, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
Jun 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 7, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 5, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
Feb 5, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
Feb 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Mar 14, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Mar 10, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
Mar 10, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
Mar 10, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 7, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Dec 13, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Dec 13, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
Nov 23, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Nov 4, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Nov 4, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Nov 4, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Nov 4, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Nov 4, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Nov 4, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Nov 4, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Nov 4, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Nov 4, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Nov 4, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Oct 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 12, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Mar 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 10, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Medicated plasters; Vaccines; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Dietary and nutritional supplements
Class 035
Wholesale distributorships and retail store services featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Wholesale store services featuring biological preparations for medical purposes; Retail store services featuring biological preparations for medical purposes; Retail store services featuring pharmaceutical preparations for the treatment of cells; Retail store services featuring medical instruments; Retail store services featuring medical apparatus; Retail store services featuring medical genetic analyzer; Retail store services featuring electromedical diagnostic instruments; Wholesale store services featuring pharmaceutical preparations for the treatment of cells; Wholesale store services featuring medical instruments; Wholesale store services featuring medical apparatus; Wholesale store services featuring medical genetic analyzer; Wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses
Class 042
Research and development of vaccines and medicines; Research and development, laboratory and scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Conducting clinical studies of medicines for medical research purposes; Clinical research in the nature of performing biopsies for medical research; Product research and development of medical products; Conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; Testing, inspection or research of pharmaceuticals; Scientific research relating to biology; Scientific research in the field of genetic engineering; Research and development of technology for biotechnology; Scientific research in the fields of biomedicine; Laboratory research in the field of biology; Product development of cell therapy products; Drug discovery services; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of gene analysis; Medical studies, namely, medical laboratory services; Research and development of technology for medicinal chemical manufacturing; Medical research services relating to clinical data
Additional Information
Design Mark
The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the stylized wording "GC Bioscience" in dark blue; the color white is not claimed as a feature of the mark and represents background and transparent areas only.
Color Claim
The color(s) green, yellow, orange, red, and dark blue is/are claimed as a feature of the mark.
Classification
International Classes
005
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCE"